v3.25.2
NON-CONTROLLING INTEREST
6 Months Ended
Jun. 30, 2025
Noncontrolling Interest [Abstract]  
NON-CONTROLLING INTEREST

NOTE 12 – NON-CONTROLLING INTEREST

  

    June 30, 2025     June 30, 2024  
Net loss Subsidiary   $     $ (27,191 )
Net loss attributable to the non-controlling interest           13,324  
Net loss affecting Bioxytran           (13,867 )
                 
Accumulated deficit           (3,955,108 )
Accumulated deficit attributable to the non-controlling interest           855,160  
Accumulated deficit affecting Bioxytran           (3,099,948 )
                 
Net equity non-controlling interest   $     $ (694,210 )

 

On August 19, 2024, the minority affiliates shareholder, the beneficial ownership of which includes the Company’s officers, exercised a warrant allowing it to exchange its 49% ownership in the Subsidiary for a 16.8% ownership of the Company.